A novel macrolide, solithromycin suppresses mucin overexpression induced by Pseudomonas aeruginosa LPS in airway epithelial cells

Yasuhide Kawamoto, Yoshitomo Morinaga*, Norihito Kaku, Naoki Uno, Kosuke Kosai, Kei Sakamoto, Hiroo Hasegawa, Katunori Yanagihara

*この論文の責任著者

研究成果: ジャーナルへの寄稿学術論文査読

5 被引用数 (Scopus)

抄録

Some macrolides such as 14- and 15-membered macrolides have immunomodulatory effects such as suppression of mucin overproduction. Because a novel macrolide, solithromycin, was developed, we examined whether it suppresses the overexpression of mucin in vitro. A human airway epithelial cell line NCI–H292 was stimulated by Pseudomonas aeruginosa lipopolysaccharides to induce the overproduction of a major mucin, MUC5AC. Treatment with 10 μg/mL of solithromycin significantly inhibited LPS-induced MUC5AC in both mRNA and protein levels as well as a 15-membered macrolide, azithromycin. These findings support that solithromycin has a potential immunomodulatory effect.

本文言語英語
ページ(範囲)1008-1010
ページ数3
ジャーナルJournal of Infection and Chemotherapy
26
9
DOI
出版ステータス出版済み - 2020/09

ASJC Scopus 主題領域

  • 微生物学(医療)
  • 感染症
  • 薬理学(医学)

フィンガープリント

「A novel macrolide, solithromycin suppresses mucin overexpression induced by Pseudomonas aeruginosa LPS in airway epithelial cells」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル